


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app19.us.archive.org';v.server_ms=385;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>The utility of positron emission tomography in epilepsy. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712205851im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712205851im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712205851im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712205851im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712205851/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712205851im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712205851cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712205851js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712205851if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712205851/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712205851if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712205851/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712205851/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712205851/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712205851/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712205851im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712205851im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712205851im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712205851/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712205851/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712205851/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712205851/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712205851/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712205851/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712205851/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712205851/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712205851/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712205851/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712205851/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712205851/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712205851/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712205851/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712205851/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712205851/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712205851/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712205851/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712205851/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712205851/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712205851/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:010642</li>
            <li>2015 Jan 29
            </li>            
                                </ul>
        <div>
                <h1>The utility of positron emission tomography in epilepsy.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712205851/https://www.guideline.gov/search?f_Guideline_Developer_String=Program%20in%20Evidence-based%20Care&amp;fLockTerm=Program%2Bin%2BEvidence-based%2BCare">Program in Evidence-based Care</a></li>
                        <li>   
                                <a id="924" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>Burneo JG, Poon R, Kellett S, Houle S, Snead OC. The utility of positron emission tomography in epilepsy. Toronto (ON): Cancer Care Ontario (CCO); 2015 Jan 29. 30 p.&nbsp;(PET recommendation report; no. 13).&nbsp; [51 references]</td></tr></table>                    <p><a href="/web/20180712205851/https://www.guideline.gov/Home/Disclaimer?id=49015&amp;contentType=fulltextlink&amp;redirect=https%253a%252f%252fwww.cancercare.on.ca%252fcommon%252fpages%252fUserFile.aspx%253ffileId%253d328569">View the original guideline documentation</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712205851im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>The PET Recommendation Report, initially the full original Guideline, over time will expand to contain new information emerging from reviewing and updating activities.</p>
<p>Please visit the <a href="https://web.archive.org/web/20180712205851/https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=328569" title="CCO Web site">Cancer Care Ontario Web site</a> for details on any new evidence that has emerged and implications to the guidelines.</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180712205851/https://www.guideline.gov/search?f_Age_of_Target_Population=Adolescent%20%2813%20to%2018%20years%29&amp;fLockTerm=Adolescent%2B%2813%2Bto%2B18%2Byears%29">Adolescent (13 to 18 years)</a></li>                      
                        <li><a href="/web/20180712205851/https://www.guideline.gov/search?f_Age_of_Target_Population=Adult%20%2819%20to%2044%20years%29&amp;fLockTerm=Adult%2B%2819%2Bto%2B44%2Byears%29">Adult (19 to 44 years)</a></li>                      
                        <li><a href="/web/20180712205851/https://www.guideline.gov/search?f_Age_of_Target_Population=Aged%20%2865%20to%2079%20years%29&amp;fLockTerm=Aged%2B%2865%2Bto%2B79%2Byears%29">Aged (65 to 79 years)</a></li>                      
                        <li><a href="/web/20180712205851/https://www.guideline.gov/search?f_Age_of_Target_Population=Aged%2C%2080%20and%20over&amp;fLockTerm=Aged%252c%2B80%2Band%2Bover">Aged, 80 and over</a></li>                      
                        <li><a href="/web/20180712205851/https://www.guideline.gov/search?f_Age_of_Target_Population=Child%20%282%20to%2012%20years%29&amp;fLockTerm=Child%2B%282%2Bto%2B12%2Byears%29">Child (2 to 12 years)</a></li>                      
                        <li><a href="/web/20180712205851/https://www.guideline.gov/search?f_Age_of_Target_Population=Infant%20%281%20to%2023%20months%29&amp;fLockTerm=Infant%2B%281%2Bto%2B23%2Bmonths%29">Infant (1 to 23 months)</a></li>                      
                        <li><a href="/web/20180712205851/https://www.guideline.gov/search?f_Age_of_Target_Population=Infant%2C%20Newborn%20%28to%201%20month%29&amp;fLockTerm=Infant%252c%2BNewborn%2B%28to%2B1%2Bmonth%29">Infant, Newborn (to 1 month)</a></li>                      
                        <li><a href="/web/20180712205851/https://www.guideline.gov/search?f_Age_of_Target_Population=Middle%20Age%20%2845%20to%2064%20years%29&amp;fLockTerm=Middle%2BAge%2B%2845%2Bto%2B64%2Byears%29">Middle Age (45 to 64 years)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180712205851/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712205851/https://www.guideline.gov/search?f_MSH_CUI=C0014547&amp;fLockTerm=Epilepsies%2c+Partial">Epilepsies, Partial</a>
, <a href="/web/20180712205851/https://www.guideline.gov/search?f_MSH_CUI=C0014544&amp;fLockTerm=Epilepsy">Epilepsy</a>
, <a href="/web/20180712205851/https://www.guideline.gov/search?f_MSH_CUI=C0046056&amp;fLockTerm=Fluorodeoxyglucose+F18">Fluorodeoxyglucose F18</a>
, <a href="/web/20180712205851/https://www.guideline.gov/search?f_MSH_CUI=C0032743&amp;fLockTerm=Positron-Emission+Tomography">Positron-Emission Tomography</a>
, <a href="/web/20180712205851/https://www.guideline.gov/search?f_MSH_CUI=C0033061&amp;fLockTerm=Preoperative+Care">Preoperative Care</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712205851/https://www.guideline.gov/search?f_MTH_CUI=C0014547&amp;fLockTerm=Epilepsies%2c+Partial">Epilepsies, Partial</a>
, <a href="/web/20180712205851/https://www.guideline.gov/search?f_MTH_CUI=C0014544&amp;fLockTerm=Epilepsy">Epilepsy</a>
, <a href="/web/20180712205851/https://www.guideline.gov/search?f_MTH_CUI=C0046056&amp;fLockTerm=Fluorodeoxyglucose+F18">Fluorodeoxyglucose F18</a>
, <a href="/web/20180712205851/https://www.guideline.gov/search?f_MTH_CUI=C0032743&amp;fLockTerm=Positron-Emission+Tomography">Positron-Emission Tomography</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712205851/https://www.guideline.gov/search?f_PDQ_CUI=C0046056&amp;fLockTerm=fludeoxyglucose+F+18">fludeoxyglucose F 18</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712205851/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0014544&amp;fLockTerm=Epilepsy">Epilepsy</a>
 (128613002), <a href="/web/20180712205851/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0014544&amp;fLockTerm=Epilepsy">Epilepsy</a>
 (84757009), <a href="/web/20180712205851/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0046056&amp;fLockTerm=Fluorodeoxyglucose+F%5e18%5e">Fluorodeoxyglucose F^18^</a>
 (35321007), <a href="/web/20180712205851/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0014547&amp;fLockTerm=Localization-related+epilepsy">Localization-related epilepsy</a>
 (230381009), <a href="/web/20180712205851/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032743&amp;fLockTerm=Positron+emission+tomography">Positron emission tomography</a>
 (363678002), <a href="/web/20180712205851/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032743&amp;fLockTerm=Positron+emission+tomography">Positron emission tomography</a>
 (82918005), <a href="/web/20180712205851/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0182349&amp;fLockTerm=Positron+emission+tomography+unit">Positron emission tomography unit</a>
 (39821008), <a href="/web/20180712205851/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0182349&amp;fLockTerm=Positron+emission+tomography+unit">Positron emission tomography unit</a>
 (462323006), <a href="/web/20180712205851/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0033061&amp;fLockTerm=Preoperative+care">Preoperative care</a>
 (133898004)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SPN</h5>
                    <div class="field-content">
<a href="/web/20180712205851/https://www.guideline.gov/search?f_SPN_CUI=C0182349&amp;fLockTerm=SYSTEM%2c+TOMOGRAPHY%2c+COMPUTED%2c+EMISSION">SYSTEM, TOMOGRAPHY, COMPUTED, EMISSION</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180712205851/https://www.guideline.gov/search?f_UMD_CUI=C0182349&amp;fLockTerm=Scanning+Systems%2c+Positron+Emission+Tomography">Scanning Systems, Positron Emission Tomography</a>
 (16-375)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712205851/https://www.guideline.gov/summaries/downloadcontent/ngc-10642?contentType=pdf" class="pdf">.PDF 90.2 kb</a></li>
                            <li><a href="/web/20180712205851/https://www.guideline.gov/summaries/downloadcontent/ngc-10642?contentType=word" class="word">Word Document 279.3 kb</a></li>
                            <li><a href="/web/20180712205851/https://www.guideline.gov/summaries/downloadcontent/ngc-10642?contentType=xml" class="xml">.XML 28.6 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712205851/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/49015/the-utility-of-positron-emission-tomography-in-epilepsy" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712205851/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/49015/the-utility-of-positron-emission-tomography-in-epilepsy" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712205851/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/49015/the-utility-of-positron-emission-tomography-in-epilepsy&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712205851/mailto:/?Subject=AHRQ: The utility of positron emission tomography in epilepsy.&amp;body=https://www.guideline.gov/summaries/summary/49015/the-utility-of-positron-emission-tomography-in-epilepsy" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: The utility of positron emission tomography in epilepsy. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2015 Jan 29. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712205851/https://www.guideline.gov/summaries/citedownload/49015?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712205851/https://www.guideline.gov/summaries/citedownload/49015?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712205851/https://www.guideline.gov/summaries/citedownload/49015?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712205851/https://www.guideline.gov/summaries/citedownload/49015?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712205851/https://www.guideline.gov/summaries/citedownload/49015?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712205851/https://www.guideline.gov/summaries/citedownload/49015">RefWorks</a></li>
                            <li><a href="/web/20180712205851/https://www.guideline.gov/summaries/citedownload/49015?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="49015" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>Recommendations</strong></p>
<ol style="list-style-type: decimal;" start="1">
    <li><sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography (PET) is recommended for the presurgical evaluation of adult and pediatric patients with medically intractable focal or partial epilepsy in the setting of a comprehensive epilepsy surgery program within a Regional Epilepsy Surgery Center of Excellence. </li>
    <li>Due to insufficient evidence, a recommendation cannot be made for or against the use of <sup>18</sup>F-FDG PET in the detection of cortical malformations in patients with intractable infantile spasms when magnetic resonance imaging (MRI) or computed tomography (CT) fails to show structural abnormalities. </li>
    <li>Due to insufficient evidence, a recommendation cannot be made for or against the use of <sup>18</sup>F-FDG PET/MRI coregistration in the presurgical evaluation of patients with medically intractable epilepsy. </li>
</ol></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>None provided</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Epilepsy</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Diagnosis</p>
                    <p>Evaluation</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Neurological Surgery</p>
                    <p>Neurology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Other</p>
                    <p>Patients</p>
                    <p>Physicians</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>To guide the Ontario Positron Emission Tomography (PET) Steering Committee in their decision making with respect to the development of indications for the use of PET in epilepsy </li>
    <li>To inform clinicians and patients who are seeking information about PET as a presurgical tool in epilepsy </li>
</ul></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Adult and pediatric patients with medically intractable epilepsy being considered for surgery</p></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><div class="content_para"><p><sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography (PET)&nbsp;for presurgical evaluation of adult and pediatric patients with medically intractable focal or partial epilepsy</p>
<p class="Note"><strong>Note</strong>: The following interventions were considered but there was insufficient evidence to make a recommendation for or against:</p>
<ul class="contentListFont">
    <li><sup>18</sup>F-FDG PET in the detection of cortical malformations in patients with intractable infantile spasms when magnetic resonance imaging (MRI) or computed tomography (CT) fail to show structural abnormalities. </li>
    <li><sup>18</sup>F-FDG PET/MRI coregistration in the presurgical evaluation of patients with medically intractable epilepsy. </li>
</ul></div></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Diagnostic accuracy (sensitivity, specificity, positive predictive value [PPV], negative predictive value [NPV]) </li>
    <li>Surgical management impact </li>
    <li>Patient outcome impact </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p><strong><span style="text-decoration: underline;">Literature Search Strategy</span></strong></p>
<p>The literature was searched using MEDLINE (1946 to September Week 4 2013) and EMBASE (1974 to 2013 Week 29) databases in OVID. The search strategy combined disease-specific terms (exp epilepsy/ or epilep$.ti,ab.) with intervention-specific terms (exp tomography, emission computed/ or pet or positron emission tomograph$ or positron-emission),ti, ab.). See Appendix 1 in the original guideline document for the search strategy.</p>
<p>In addition, annual meetings of the American Epilepsy Society (<a href="/web/20180712205851/https://www.guideline.gov/Home/Disclaimer?id=49015&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.aesnet.org%2fmeetings_events%2fannual_meeting_abstracts" title="American Epilepsy Society Web site">https://www.aesnet.org/meetings_events/annual_meeting_abstracts</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712205851im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>) were searched up to September 2013 for other relevant abstracts. Likewise, the </p>
<ul style="list-style-type: disc;">
    <li>Canadian Medical Association Infobase (<a href="/web/20180712205851/https://www.guideline.gov/Home/Disclaimer?id=49015&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.cma.ca%2fEn%2fPages%2fclinical-practice-guidelines.aspx" title="CMA InfoBase Web site">https://www.cma.ca/En/Pages/clinical-practice-guidelines.aspx</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712205851im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>) </li>
    <li>National Guideline Clearinghouse (<a href="https://web.archive.org/web/20180712205851/http://www.guideline.gov/" target="_blank" title="NGC Web site">http://www.guideline.gov/</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712205851im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>) </li>
    <li>And Cochrane Database of Systematic Reviews (<a href="/web/20180712205851/https://www.guideline.gov/Home/Disclaimer?id=49015&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.thecochranelibrary.com%2fview%2f0%2findex.html" title="Cochrane Database Web site">http://www.thecochranelibrary.com/view/0/index.html</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712205851im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>) </li>
</ul>
<p>were searched up to September 2013 for existing evidence-based practice guidelines. Relevant articles and abstracts were selected and reviewed by two reviewers, and the reference lists from these were searched for additional studies, as were the reference lists from relevant review articles.</p>
<p><strong><span style="text-decoration: underline;">Study Selection Criteria</span></strong></p>
<p><strong>Inclusion Criteria</strong></p>
<p>Fully published reports or abstracts that met the following criteria were selected for inclusion:</p>
<ul style="list-style-type: disc;">
    <li>Systematic reviews, randomized controlled trials (RCTs), and prospective or retrospective studies that evaluated the use of <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) positron emission tomography (PET) in medically intractable epilepsy </li>
    <li>Studies that included &ge;12 patients of any age </li>
    <li>Reported on at least one of the following outcomes: diagnostic accuracy (sensitivity, specificity, positive predictive value [PPV], negative predictive value [NPV]), surgical management impact, or patient outcome impact </li>
    <li>Studies that used a suitable reference standard (intracranial electroencephalogram (EEG), surgical eligibility, good surgical outcome [Engel class I, II, or III]) when appropriate </li>
</ul>
<p><strong>Exclusion Criteria</strong></p>
<ul style="list-style-type: disc;">
    <li>Studies of non-<sup>18</sup>F-FDG PET </li>
    <li>Non-systematic reviews, letters, editorials, individual case reports, historical articles, or commentaries </li>
    <li>Reports published in a language other than English </li>
</ul>
<p><strong>Literature Search Results</strong></p>
<p>No existing systematic reviews or evidence-based guidelines were found that specifically evaluated the use of <sup>18</sup>F-FDG PET against a suitable reference standard. In addition, there were no RCTs comparing the diagnostic accuracy and clinical utility of <sup>18</sup>F-FDG PET with intracranial electroencephalogram (EEG). However, 36 retrospective studies and three prospective studies were identified to be relevant to this recommendation report (see Figure 1 in the original guideline document). Six of these studies were reported solely in abstract form, while two studies had both the full publication and the abstract. The eligible studies were conducted in various contexts but the Working Group believed the outcomes valued in this report would be relevant to the Regional Epilepsy Surgery Centres of Excellence context.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>39 studies were included in the qualitative synthesis (36 retrospective studies and three prospective studies).</p>
<p>See Figure 1 in the original guideline document for a literature flow diagram.</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p>Not applicable</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Systematic Review with Evidence Tables</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>Synthesizing the Evidence</strong></p>
<p>Due to the heterogeneity of the studies in the patient population, study design, outcome measurements, and methods of positron emission tomography (PET) interpretation, the results of the studies included in the systematic review could not be pooled. An assessment of study quality was performed for all fully published reports by one methodologist.</p>
<p><strong>Study Design and Quality</strong></p>
<p>For the fully published reports, study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool (see Appendix II in the original guideline document). Abstracts were not assessed due to limited reporting of study information. The overall quality varied among the studies but the large majority were judged to have low risk of bias. The most common concern was the influence of PET results on the interpretation of the reference standard. That is, localization with intracranial electroencephalogram (EEG), decision to perform surgery, and classification of surgical outcomes were often not blinded to PET findings. Furthermore, some studies excluded patients with magnetic resonance imaging (MRI) abnormalities (i.e., structural lesions), incomplete tests or short follow-up, lost to follow up, or a definite extratemporal seizure origin.</p>
<p>Refer to the "Results" section in the original guideline document for further information concerning the analysis of the evidence.</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p>This recommendation report, produced by the Program in Evidence-based Care (PEBC) and the Ontario Positron Emission Tomography (PET) Steering Committee of Cancer Care Ontario, was developed through a systematic review of the available evidence. The body of evidence, which forms the basis of the recommendations, was reviewed by two clinical experts in the epilepsy field, two methodologists, and one member of the PET Steering Committee (imaging expert in mental illness and addictions).</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p>Not applicable</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Not stated</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>Not applicable</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The recommendations are supported by prospective and retrospective studies.</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><div class="content_para"><p>The potential benefit of positron emission tomography (PET) in the presurgical evaluation of patients with intractable epilepsy lies in its ability to provide data for localizing the seizure focus and to determine resectability. The evidence from the review proposes that PET is able to provide complementary information that can guide decision making toward successful surgery.</p></div></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><div class="content_para"><p>False negative results of positron emission tomography (PET)</p></div></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Care has been taken in the preparation of the information contained in this report. Nonetheless, any person seeking to apply or consult the report is expected to use independent medical judgment in the context of individual clinical circumstances or seek out the supervision of a qualified clinician. Cancer Care Ontario makes no representation or guarantees of any kind whatsoever regarding the report content or use or application and disclaims any responsibility for its application or use in any way. </li>
    <li>For localizing epileptic foci or guiding intracranial electrode placement as part of the presurgical evaluation in a Regional Epilepsy Surgery Center of Excellence, patients with temporal lobe epilepsy may benefit more from positron emission tomography (PET) than patients with extratemporal lobe epilepsy. </li>
    <li>The evidence is suggestive that localization is greater when PET is assessed using statistical parametric mapping (SPM) and this method may be superior to visual interpretation for particular types of epilepsy. However, defining the exact group of patients for whom PET is likely to provide enhanced localization information based on SPM is beyond the scope of this report. </li>
    <li>Patients with intractable infantile spasms exhibiting focal metabolic abnormality on PET could be considered for surgery, provided that epileptogenicity of focal malformation is confirmed electrographically during the presurgical evaluation in a Regional Epilepsy Surgery Centre of Excellence. Surgery would not be considered based solely upon a focal area of hypometabolism on PET without other corroborating data. </li>
</ul></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>
                        <h3><a href="#">Implementation Tools</a></h3>
                    <p>Quick Reference Guides/Physician Guides</p>
                    <p><div class="general-block">For information about availability, see the <i>Availability of Companion Documents</i> and <i>Patient Resources</i> fields below.</div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Getting Better</p>
                    <p>Living with Illness</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>Burneo JG, Poon R, Kellett S, Houle S, Snead OC. The utility of positron emission tomography in epilepsy. Toronto (ON): Cancer Care Ontario (CCO); 2015 Jan 29. 30 p.&nbsp;(PET recommendation report; no. 13).&nbsp; [51 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2015 Jan 29</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]</p>
                        <h3><a href="#">Guideline Developer Comment</a></h3>
                    <p><div class="content_para"><p>The Program in Evidence-based Care (PEBC) is a Province of Ontario initiative sponsored by Cancer Care Ontario and the Ontario Ministry of Health and Long-Term Care.</p></div></p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>The Program in Evidence-based Care (PEBC) is a provincial initiative of Cancer Care Ontario supported by the Ontario Ministry of Health and Long-Term Care. All work produced by the PEBC is editorially independent from the Ontario Ministry of Health and Long-Term Care.</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>Utility of Positron Emission Tomography in Epilepsy Working Group</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p><em>Authors</em>: J.G. Burneo, R. Poon, S. Kellett, S. Houle, O.C. Snead</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>The authors and reviewers reported that they had no conflicts of interest.</p></div></p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p>
<p>The PET Recommendation Report, initially the full original Guideline, over time will expand to contain new information emerging from reviewing and updating activities.</p>
<p>Please visit the <a href="/web/20180712205851/https://www.guideline.gov/Home/Disclaimer?id=49015&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.cancercare.on.ca%2fcommon%2fpages%2fUserFile.aspx%3ffileId%3d328569" title="CCO Web site">Cancer Care Ontario Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712205851im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> for details on any new evidence that has emerged and implications to the guidelines.</p>
<p>This guideline meets NGC's 2013 (revised) inclusion criteria.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>Electronic copies: Available from the <a href="/web/20180712205851/https://www.guideline.gov/Home/Disclaimer?id=49015&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.cancercare.on.ca%2fcommon%2fpages%2fUserFile.aspx%3ffileId%3d328569" title="Cancer Care Ontario Web site">Cancer Care Ontario Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712205851im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>The following are available:</p>
<ul style="list-style-type: disc;">
    <li>The utility of positron emission tomography in epilepsy. Summary. Toronto (ON): Cancer Care Ontario; 2015 Jan 29. 3 p. Electronic copies: Available from the <a href="/web/20180712205851/https://www.guideline.gov/Home/Disclaimer?id=49015&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.cancercare.on.ca%2fcommon%2fpages%2fUserFile.aspx%3ffileId%3d328571" title="Cancer Care Ontario Web site">Cancer Care Ontario (CCO) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712205851im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
    <li>Program in Evidence-based Care handbook. Toronto (ON): Cancer Care Ontario (CCO); 2012. 14 p. Electronic copies: Available from the <a href="/web/20180712205851/https://www.guideline.gov/Home/Disclaimer?id=49015&amp;contentType=summary&amp;redirect=https%3a%2f%2fwww.cancercare.on.ca%2fcommon%2fpages%2fUserFile.aspx%3ffileId%3d50876" title="Cancer Care Ontario Web site">CCO Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712205851im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This NGC summary was completed by ECRI Institute on March 20, 2015.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Please refer to the <a href="/web/20180712205851/https://www.guideline.gov/Home/Disclaimer?id=49015&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.cancercare.on.ca%2fontariocancernews%2fcopyright.html" title="CCO Web site">Copyright and Disclaimer Statements</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712205851im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/> posted at the Program in Evidence-based Care section of the Cancer Care Ontario Web site.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712205851/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712205851/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712205851/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712205851/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712205851/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712205851/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712205851/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712205851/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712205851/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712205851/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712205851/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712205851/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712205851/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712205851/https://www.guideline.gov/disclaimer?id=49015&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712205851im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712205851im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712205851/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712205851/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712205851/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712205851/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712205851/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712205851/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712205851/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712205851/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712205851/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712205851/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712205851/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712205851/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712205851/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712205851/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712205851/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712205851/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712205851/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712205851/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712205851/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712205851im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712205851im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712205851/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712205851im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712205851im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712205851/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712205851/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712205851js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712205851js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 20:58:51 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:32:04 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 304.181 (3)
  esindex: 0.008
  captures_list: 326.613
  CDXLines.iter: 17.621 (3)
  PetaboxLoader3.datanode: 136.794 (4)
  exclusion.robots: 0.183
  exclusion.robots.policy: 0.172
  RedisCDXSource: 0.658
  PetaboxLoader3.resolve: 169.194
  load_resource: 24.573
-->